Get informed when a big investor buys or sells
+ Follow4.89%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for ESALF is 4.89%. That is below the Healthcare sector average of 13.1%. Investors often review this figure alongside Eisai , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, ESALF currently prints 4.89% for ROE, while the sector average sits near 13.1%. That is roughly 62.7% below the sector mean. Large gaps often invite a closer look at Eisai , Ltd.'s growth, margins, and balance sheet.
Return on Equity shows how effectively Eisai , Ltd. converts resources into returns. At 4.89%, ESALF may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting ESALF's ROE (4.89%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Eisai , Ltd.'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.